Altimmune (ALT) Short-Term Debt issuances (2012 - 2014)
Altimmune's (ALT) quarterly Short-Term Debt issuances came in at -$1.1 million in Q1 2014, down 85593.88% year-on-year from N/an in Q1 2013, and down 200.0% on a QoQ basis from $1.1 million in Q4 2013.
Altimmune (ALT) Short-Term Debt issuances (2012 - 2014) Analysis & Trends
Altimmune (ALT) has 3 years of Short-Term Debt issuances data on file, last reported at -$1.1 million in Q1 2014.
- On a quarterly basis, Short-Term Debt issuances fell 85593.88% year-over-year to -$1.1 million in Q1 2014; TTM through Dec 2014 was -$1.1 million, a 357.24% decrease from a year earlier, with the FY2014 full-year figure at -$1.1 million, down 357.24% from the prior year.
- Short-Term Debt issuances for Q1 2014 stood at -$1.1 million, down from $1.1 million in the prior quarter.
- Over the last five years, Short-Term Debt issuances for ALT reached as high as $1.1 million in Q4 2013 and fell as low as -$1.2 million in Q3 2013.
- Historically, Short-Term Debt issuances has averaged -$50080.3 across 3 years, with a median of -$1274.0 in 2013.
- Across the five-year window, Short-Term Debt issuances jumped 793.87% in 2013 and tumbled 85593.88% in 2014, its largest moves.
- Year by year, Short-Term Debt issuances stood at $122137.0 in 2012, then soared by 793.87% to $1.1 million in 2013, then slumped by 200.0% to -$1.1 million in 2014.
- Per Business Quant data, the three most recent Short-Term Debt issuances figures were -$1.1 million in Q1 2014, $1.1 million in Q4 2013, and -$1.2 million in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 58.20 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -1.09 Mn |
| Mar 31, 2014 | -1.09 Mn |
| Dec 31, 2013 | 1.09 Mn |
| Dec 31, 2013 | 1.09 Mn |
| Sep 30, 2013 | -1.17 Mn |
| Sep 30, 2013 | -1.17 Mn |
| Jun 30, 2013 | -161,090.00 |
| Jun 30, 2013 | -161,090.00 |
| Mar 31, 2013 | -1,274.00 |
| Mar 31, 2013 | -1,274.00 |
| Dec 31, 2012 | 122,137.00 |
| Dec 31, 2012 | 122,137.00 |
| Mar 31, 2012 | 857,808.00 |
| Mar 31, 2012 | 857,808.00 |